These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21979801)

  • 41. The effect of repeat exercise on pulmonary diffusing capacity and EIH in trained athletes.
    McKenzie DC; Lama IL; Potts JE; Sheel AW; Coutts KD
    Med Sci Sports Exerc; 1999 Jan; 31(1):99-104. PubMed ID: 9927016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components.
    Hughes JM; Pride NB
    Am J Respir Crit Care Med; 2012 Jul; 186(2):132-9. PubMed ID: 22538804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postexercise reduction in lung diffusion capacity is not attenuated by skin cooling.
    Storebø ML; Hope A; Vaagbø G; Thorsen E
    Clin Physiol Funct Imaging; 2008 Nov; 28(6):403-8. PubMed ID: 18700837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variation of αENaC influences lung diffusion during exercise in humans.
    Baker SE; Wheatley CM; Cassuto NA; Foxx-Lupo WT; Sprissler R; Snyder EM
    Respir Physiol Neurobiol; 2011 Dec; 179(2-3):212-8. PubMed ID: 21893217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sildenafil improves the alveolar-capillary function in heart failure patients.
    Bussotti M; Montorsi P; Amato M; Magini A; Baldassarre D; Tantardini F; Veglia F; Agostoni P
    Int J Cardiol; 2008 May; 126(1):68-72. PubMed ID: 17490765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
    Zile MR; Bourge RC; Redfield MM; Zhou D; Baicu CF; Little WC
    JACC Heart Fail; 2014 Apr; 2(2):123-30. PubMed ID: 24720918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume.
    van der Lee I; Zanen P; Stigter N; van den Bosch JM; Lammers JW
    Respir Med; 2007 Jul; 101(7):1579-84. PubMed ID: 17229562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prior maximal exercise decreases pulmonary diffusing capacity during subsequent exercise.
    Baldi JC; Dacey MJ; Lee MJ; Coast JR
    Int J Sports Med; 2014 Nov; 35(12):982-6. PubMed ID: 24838265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients.
    Barisione G; Bacigalupo A; Brusasco C; Scanarotti C; Penco S; Bassi AM; Lamparelli T; Garlaschi A; Pellegrino R; Brusasco V
    Respir Physiol Neurobiol; 2014 Apr; 194():54-61. PubMed ID: 24495442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interstitial lung fluid balance in healthy lowlanders exposed to high-altitude.
    Taylor BJ; Stewart GM; Marck JW; Summerfield DT; Issa AN; Johnson BD
    Respir Physiol Neurobiol; 2017 Sep; 243():77-85. PubMed ID: 28554819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.
    Fischler M; Maggiorini M; Dorschner L; Debrunner J; Bernheim A; Kiencke S; Mairbäurl H; Bloch KE; Naeije R; Brunner-La Rocca HP
    Am J Respir Crit Care Med; 2009 Aug; 180(4):346-52. PubMed ID: 19520908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m.
    Siebenmann C; Bloch KE; Lundby C; Nussbamer-Ochsner Y; Schoeb M; Maggiorini M
    High Alt Med Biol; 2011; 12(2):169-77. PubMed ID: 21718165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.
    Falk B; Nini A; Zigel L; Yahav Y; Aviram M; Rivlin J; Bentur L; Avital A; Dotan R; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):234-41. PubMed ID: 16429430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A small amount of inhaled nitric oxide does not increase lung diffusing capacity.
    Zavorsky GS; Murias JM
    Eur Respir J; 2006 Jun; 27(6):1251-7. PubMed ID: 16540495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sitaxsentan therapy for pulmonary arterial hypertension.
    Barst RJ; Langleben D; Frost A; Horn EM; Oudiz R; Shapiro S; McLaughlin V; Hill N; Tapson VF; Robbins IM; Zwicke D; Duncan B; Dixon RA; Frumkin LR;
    Am J Respir Crit Care Med; 2004 Feb; 169(4):441-7. PubMed ID: 14630619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
    Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maximal aerobic capacity at several ambient concentrations of carbon monoxide at several altitudes.
    Horvath SM; Agnew JW; Wagner JA; Bedi JF
    Res Rep Health Eff Inst; 1988 Dec; (21):1-21. PubMed ID: 3269259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production.
    Guazzi M; Arena R; Vicenzi M; Guazzi MD
    Acta Physiol (Oxf); 2009 Jun; 196(2):267-77. PubMed ID: 19032601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.